0.622 USD
-0.07 (-9.72%)
0.6288 USD
+0.01 (+1.09%)
ChartMill assigns a Buy % Consensus number of 43% to BLCM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 719.94% above the current price.
BLCM was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about BLCM.
In the previous month the buy percentage consensus was at a similar level.
BLCM was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-02-16 | Ladenburg Thalmann | Initiate | Buy |
BELLICUM PHARMACEUTICALS INC / BLCM FAQ
What do analysts expect the price target to be for BELLICUM PHARMACEUTICALS INC (BLCM)?
6 analysts have analysed BLCM and the average price target is 5.1 USD. This implies a price increase of 719.94% is expected in the next year compared to the current price of 0.622.
What is the consensus rating for BLCM stock?
The consensus rating for BELLICUM PHARMACEUTICALS INC (BLCM) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for BLCM stock?
The number of analysts covering BELLICUM PHARMACEUTICALS INC (BLCM) is 6.